T
Timothy M. Uyeki
Researcher at Centers for Disease Control and Prevention
Publications - 338
Citations - 47420
Timothy M. Uyeki is an academic researcher from Centers for Disease Control and Prevention. The author has contributed to research in topics: Influenza A virus subtype H5N1 & Influenza A virus. The author has an hindex of 86, co-authored 309 publications receiving 42818 citations. Previous affiliations of Timothy M. Uyeki include National Center for Immunization and Respiratory Diseases & University of California, San Francisco.
Papers
More filters
Journal ArticleDOI
Ebola virus disease: What clinicians in the United States need to know.
TL;DR: Enhanced understanding of EVD case definitions, clinical presentation, treatment procedures, and infection control strategies will improve the ability of health care workers to provide safe care for patients with EVD.
Journal ArticleDOI
No evidence of avian influenza A (H5N1) among returning US travelers.
Justin R. Ortiz,Teresa R. Wallis,Mark A. Katz,LaShondra Berman,Amanda Balish,Stephen Lindstrom,Vic Veguilla,Kathryn S. Teates,Jacqueline M. Katz,Alexander Klimov,Timothy M. Uyeki +10 more
TL;DR: Among the 59 reported patients, no evidence of H5N1 virus infection was found; none had had direct contact with poultry, but 42% had evidence of human influenza A.
Book ChapterDOI
Avian Influenza A (H5N1) Virus
Justin R. Ortiz,Timothy M. Uyeki +1 more
TL;DR: The key to preventing human infections with H5N1 virus is to avoid unprotected direct contact with diseased and dead poultry, materials contaminated by poultry feces, and uncooked or inadequately cooked poultry or poultry products.
Journal ArticleDOI
Clinical Development of Therapeutic Agents for Hospitalized Patients With Influenza: Challenges and Innovations.
James C King,John H. Beigel,Michael G. Ison,Richard E. Rothman,Timothy M. Uyeki,Robert E. Walker,James D. Neaton,John S. Tegeris,James A Zhou,Kimberly L. Armstrong,Wendy Carter,Peter Miele,Melissa S. Willis,Andrea F. Dugas,La Ree A. Tracy,David M. Vock,Rick A. Bright +16 more
TL;DR: Data received by the WG indicated that hospital-based influenza therapeutic trials could use ordinal outcome analyses, ED triage to identify influenza patients, and NEWS for enrollment criteria, which indicated that ordinal outcomes might be a more powerful primary endpoint.